Texas Cancer Institute in Hot Water, Again

The Cancer Prevention and Research Institute of Texas is under investigation following further concerns about the legitimacy of its grant review process.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, SUSAN ARNOLDThe District Attorney (DA) of Travis County, Texas, is investigating the Cancer Prevention and Research Institute of Texas (CPRIT) in Austin for possible criminal activity surrounding a recent round of grants it dished out, Nature reported. Concerns seem to revolve around awards given to companies owned by Dallas businessman David Shanahan, who was a major campaign contributor to both Texas governor Rick Perry and Lieutenant Governor David Dewhurst, “who control many of the levers when state dollars are handed out for economic development programs,” The Dallas Morning News reported. Though Shanahan claimed that his campaign contributions—$20,000 to Dewhurst and $15,000 to Perry since 2007—had “no impact of which I am aware” on the public dollars his companies received, his awards from CPRIT came despite receiving low scores from grant reviewers there, raising questions about the politics of CPRIT’s funding mechanism.

By awarding more money to Texas companies, as opposed to university researchers, “there is much more of a chance, using this mechanism, for favoritism to be given, and for politics to be inserted into the process,” J. Wade Harper, a Harvard Medical School professor, told The Dallas Morning News. Citing concerns over the integrity of its peer-review process, Harper recently resigned from CPRIT’s team of reviews—along with many of the rest of the 100 researchers that made up the agency’s expert roster, as well as its entire 8-member scientific review council. These resignations followed those of Nobel Laureate Alfred Gilman, who had served as CPRIT’s chief scientific officer, and another Nobel Prize-winner, Phillip Sharp of the Massachusetts Institute of Technology, former chair of the review ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo